Biota Holdings Limited
585 Blackburn Road
Unit 10
Notting Hill
Victoria
3168
Tel: 61-3-9915-3700
Fax: 61-3-9915-3702
Website: http://www.biota.com.au/
Email: info@biota.com.au
46 articles about Biota Holdings Limited
-
Nabi Biopharmaceuticals Effects Reverse Stock Split and Announces the Completion of and Final Exchange Ratio for the Business Combination Transaction With Biota Holdings Limited
11/9/2012
-
Nabi Biopharmaceuticals Announces Nabi Stockholder Meeting Results and the Approval of the Business Combination Transaction by Biota Holdings Limited Stockholders
10/24/2012
-
Biota Holdings Limited Announces Approval of Definitive Merger Agreement by Nabi Biopharmaceuticals Shareholders
10/23/2012
-
Nabi Biopharmaceuticals Announces Exchange Ratio for Proposed Business Combination Transaction With Biota Holdings Limited
10/19/2012
-
Two Major Independent Proxy Advisory Firms Recommend Nabi Biopharmaceuticals Stockholders Support Amended Transaction With Biota Holdings Limited at October 22nd Reconvened Special Meeting
10/16/2012
-
Biota Holdings Limited in Advanced Discussions With Russell H. Plumb to Assume Role of President and CEO of Biota Pharmaceuticals, Inc.
9/7/2012
-
Biota Holdings Limited Shareholders Meeting on Proposed Merger With Nabi Biopharmaceuticals
8/10/2012
-
Biota Holdings Limited Announces Inavir(R) Royalty Results for Q312 and Phase III Prevention Study Update
5/14/2012
-
Nabi Biopharmaceuticals Merges With Biota Holdings Limited to Create a $250 Million Group; Biota to Move to the US
4/23/2012
-
AMRI Announces Development and Manufacturing Deal with Biota Holdings Limited
4/17/2012
-
Biota Holdings Limited Announces Positive Phase IIb Data for Asthmatic Patients With Human Rhinovirus Infection (HRV)
3/28/2012
-
Biota Holdings Limited Announces Preliminary Full Year Report
8/17/2011
-
Biota Holdings Limited Release: Inavir(R) Approved for Sale in Japan
9/13/2010
-
Biota Holdings Limited CEO on FY10 Results
8/18/2010
-
Biota Holdings Limited Announces Relenza Royalty for December 2009 Quarter
2/5/2010
-
Biota Holdings Limited Appoints New Director
2/1/2010
-
Biota Holdings Limited Acquires The Antibacterial Assets Of Prolysis Limited
11/12/2009
-
Biota Holdings Limited Reports Relenza Q4 Royalty $8.9 Million
7/23/2009
-
Biota Holdings Limited Notes Important Initiatives By GSK to Respond to the New Influenza A (H1N1) Strain
5/4/2009
-
Biota Holdings Limited Announced Thier Relenza Royalty for March 2009 Quarter At A$32.3 Million
4/23/2009